Primary phospholipase C and brain disorders.

In the brain, the primary phospholipase C (PLC) proteins, PLCβ, and PLCγ, are activated primarily by neurotransmitters, neurotrophic factors, and hormones through G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). Among the primary PLC isozymes, PLCβ1, PLCβ4, and PLCγ1 are highly expressed and differentially distributed, suggesting a specific role for each PLC subtype in different regions of the brain. Primary PLCs control neuronal activity, which is important for synapse function and development. In addition, dysregulation of primary PLC signaling is linked to several brain disorders including epilepsy, schizophrenia, bipolar disorder, Huntington's disease, depression and Alzheimer's disease. In this review, we included current knowledge regarding the roles of primary PLC isozymes in brain disorders.

[1]  M. Alda,et al.  Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder. , 2001, American journal of medical genetics.

[2]  V. L. Vasco,et al.  Deletion of PLCB1 gene in schizophrenia-affected patients , 2011, Journal of cellular and molecular medicine.

[3]  S. Rhee,et al.  Activation of Phospholipase C-γ by the Concerted Action of Tau Proteins and Arachidonic Acid* , 1996, Journal of Biological Chemistry.

[4]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[5]  S. Jenkins,et al.  Tau complexes with phospholipase C‐γ in situ , 1998 .

[6]  R. Hashimoto,et al.  A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity , 2006, Molecular Psychiatry.

[7]  H. Scharfman,et al.  Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex , 1999, Neuroscience.

[8]  G. Wilcock,et al.  Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. , 1999, Biochemical and biophysical research communications.

[9]  James F. Gusella,et al.  Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.

[10]  A. Sampson,et al.  Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia , 2005, The Journal of Neuroscience.

[11]  Hitoshi Takahashi,et al.  Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y , 1999, Brain Research.

[12]  S. Watson,et al.  Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia , 2004, Biological Psychiatry.

[13]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[14]  S. Ryu,et al.  Phospholipase C-gamma 1 involved in brain disorders , 2013 .

[15]  H. Koh,et al.  Phospholipase C-β1 and schizophrenia-related behaviors. , 2013, Advances in biological regulation.

[16]  Eduardo D. Martín,et al.  Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: Involvement of phospholipaseCγ activity and glutamate receptor expression , 2009, Neuroscience.

[17]  Alessandro Poli,et al.  PLC and PI3K/Akt/mTOR signalling in disease and cancer. , 2015, Advances in biological regulation.

[18]  M. Orsetti,et al.  Some molecular effectors of antidepressant action of quetiapine revealed by DNA microarray in the frontal cortex of anhedonic rats , 2009, Pharmacogenetics and genomics.

[19]  Masahiko Watanabe,et al.  Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cβ in mouse brain , 1998, The European journal of neuroscience.

[20]  S. Zeiler,et al.  Development/Plasticity/Repair Brain-Derived Neurotrophic Factor Is Required for the Maintenance of Cortical Dendrites , 2022 .

[21]  G. Borsani,et al.  Gene expression profile in fibroblasts of Huntington's disease patients and controls , 2014, Journal of the Neurological Sciences.

[22]  H. Akil,et al.  Serotonin 5-HT 1 A , 5-HT 1 B , and 5-HT 2 A Receptor mRNA Expression in Subjects with Major Depression , Bipolar Disorder , and Schizophrenia , 2004 .

[23]  S. Gabriel,et al.  Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus , 2002, Molecular Psychiatry.

[24]  Yong Ryoul Yang,et al.  The physiological roles of primary phospholipase C. , 2013, Advances in biological regulation.

[25]  E. Tolosa,et al.  BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. , 1999, Journal of neuropathology and experimental neurology.

[26]  R. S. Sloviter,et al.  Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. , 1987, Science.

[27]  E. Stordal,et al.  The phospholipase C‐γ1 gene (PLCG1) and lithium‐responsive bipolar disorder: re‐examination of an intronic dinucleotide repeat polymorphism , 2001, Psychiatric genetics.

[28]  H. Scharfman,et al.  Brain-derived neurotrophic factor. , 2004, Growth factors.

[29]  A. Hannan,et al.  Phospholipase C Beta 1 Expression in the Dorsolateral Prefrontal Cortex from Patients with Schizophrenia at Different Stages of Illness , 2011, The Australian and New Zealand journal of psychiatry.

[30]  Gavin P. Reynolds,et al.  The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders , 2004, Neuroscience Letters.

[31]  N. Nathanson.  A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. McNamara,et al.  Disruption of TrkB-Mediated Phospholipase Cγ Signaling Inhibits Limbic Epileptogenesis , 2010, The Journal of Neuroscience.

[33]  T. Taniguchi,et al.  Differential involvement of phospholipase C isozymes in Alzheimer's disease. , 1995, Gerontology.

[34]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[35]  M. Zvelebil,et al.  Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.

[36]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[37]  V. L. Lo Vasco,et al.  Phosphoinositide-specific Phospholipase C β1 gene deletion in bipolar disorder affected patient , 2012, Journal of Cell Communication and Signaling.

[38]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[39]  R. Duman,et al.  Pathophysiology of depression: the concept of synaptic plasticity , 2002, European Psychiatry.

[40]  R. Faull,et al.  Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.

[41]  Colin Blakemore,et al.  PLC-β1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex , 2001, Nature Neuroscience.

[42]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[43]  H. Kondo,et al.  Localization of mRNAs for three novel members (β3, β4 and γ2) of phospholipase C family in mature rat brain , 1994, Neuroscience Letters.

[44]  B. Frey,et al.  Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes , 2006, Neuroscience Letters.

[45]  A. Pillai,et al.  TrkB interacts with ErbB4 and regulates NRG1-induced NR2B phosphorylation in cortical neurons before synaptogenesis , 2014, Cell Communication and Signaling.

[46]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[47]  S. Roper,et al.  Altered mRNA expression for brain‐derived neurotrophic factor and type II calcium/Calmodulin‐dependent protein kinase in the hippocampus of patients with intractable temporal lobe epilepsy , 2000, The Journal of comparative neurology.

[48]  J. Poirier,et al.  Non‐steroidal anti‐inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein , 2003, The European journal of neuroscience.

[49]  Steven W. Flavell,et al.  Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. , 2008, Annual review of neuroscience.

[50]  O. Snead,et al.  Basic mechanisms of generalized absence seizures , 1995, Annals of neurology.

[51]  B. Dean,et al.  The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. , 1996, Molecular psychiatry.

[52]  Hongyan Zhang,et al.  Association study of neuregulin 1 gene with schizophrenia , 2003, Molecular Psychiatry.

[53]  J. Gorski,et al.  Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.

[54]  I. Ferrer,et al.  Brain-derived neurotrophic factor in Huntington disease , 2000, Brain Research.

[55]  R. Duman,et al.  Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment , 2006, Hippocampus.

[56]  Hee-Sup Shin,et al.  Deletion of phospholipase C β4 in thalamocortical relay nucleus leads to absence seizures , 2009, Proceedings of the National Academy of Sciences.

[57]  S. Snyder,et al.  Brain phospholipase C isozymes: differential mRNA localizations by in situ hybridization. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Ryu,et al.  Phospholipase C isozymes selectively couple to specific neurotransmitter receptors , 1997, Nature.

[59]  R. Neve,et al.  Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect , 2001, Biological Psychiatry.

[60]  D. Baylor,et al.  Phospholipase C β4 is involved in modulating the visual response in mice , 1996 .

[61]  J. Lee,et al.  Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cβ1 , 2007, Genes, brain, and behavior.

[62]  G. García del Caño,et al.  Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons. , 2014, Advances in biological regulation.

[63]  J. McNamara,et al.  Ontogeny of seizure‐induced increases in BDNF immunoreactivity and TrkB receptor activation in rat hippocampus , 2004, Hippocampus.

[64]  E. Elliott,et al.  Brain‐derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI‐3Kinase signalling mechanism , 2005, The European journal of neuroscience.

[65]  BDNF-, IGF-1- and GDNF-Secreting Human Neural Progenitor Cells Rescue Amyloid β-Induced Toxicity in Cultured Rat Septal Neurons , 2011, Neurochemical Research.

[66]  D. Baylor,et al.  Phospholipase C beta 4 is involved in modulating the visual response in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Yogesh K. Dwivedi,et al.  Single and Repeated Stress-Induced Modulation of Phospholipase C Catalytic Activity and Expression: Role in LH Behavior , 2005, Neuropsychopharmacology.

[68]  S. Ryu,et al.  Phospholipase C-γ1 involved in brain disorders. , 2013, Advances in biological regulation.

[69]  R. Holsinger,et al.  Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? , 2002, Journal of neural transmission. Supplementum.

[70]  T. Kataoka,et al.  Multiple roles of phosphoinositide-specific phospholipase C isozymes. , 2008, BMB reports.

[71]  Zhongming Zhao,et al.  Enriched pathways for major depressive disorder identified from a genome-wide association study. , 2012, The international journal of neuropsychopharmacology.

[72]  G. Johnson,et al.  Tau complexes with phospholipase C-gamma in situ. , 1998, Neuroreport.

[73]  J. McNamara,et al.  Conditional Deletion of TrkB but Not BDNF Prevents Epileptogenesis in the Kindling Model , 2004, Neuron.

[74]  Noboru Kitamura,et al.  Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[75]  I. Scheffer,et al.  Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. , 2010, Brain : a journal of neurology.

[76]  Zhen Yan,et al.  Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.

[77]  M. Alda,et al.  Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder , 1998, Molecular Psychiatry.

[78]  E. Castrén,et al.  Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain , 2007, Neuropsychopharmacology.

[79]  T. Bonhoeffer,et al.  Mechanism of TrkB-Mediated Hippocampal Long-Term Potentiation , 2002, Neuron.

[80]  Emma L. Burrows,et al.  Phospholipase C-β1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration , 2008, Molecular Psychiatry.

[81]  O. Tanaka,et al.  Localization of mRNAs for three novel members (beta 3, beta 4 and gamma 2) of phospholipase C family in mature rat brain. , 1994, Neuroscience letters.

[82]  I. Scheffer,et al.  Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy , 2012, Epilepsia.

[83]  S. Antonarakis,et al.  An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2–q11.2 in a large Turkish pedigree , 2001, European Journal of Human Genetics.

[84]  Hui Yang,et al.  Calcium-related signaling pathways contributed to dopamine-induced cortical neuron apoptosis , 2011, Neurochemistry International.

[85]  O. Shirakawa,et al.  Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia , 1999, Biological Psychiatry.

[86]  M. Schwald,et al.  Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. , 2005, Brain research. Molecular brain research.

[87]  John R. Huguenard,et al.  Thalamic synchrony and dynamic regulation of global forebrain oscillations , 2007, Trends in Neurosciences.

[88]  J. Kleinman,et al.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia , 2003, Molecular Psychiatry.

[89]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.